Providence recently launched a program to expand its patients’ access to in-home physical therapy. The health system is launching the initiative in partnership with Luna, a provider of in-home outpatient physical therapy that serves…
Continue Reading
Health data interoperability recently took a major step forward when the U.S. Department of Health and Human Services announced the first six organizations as Qualified Health Information Networks (QHINs) under the Trusted Exchange Framework…
Continue Reading
After the Centers for Medicare and Medicaid Services put out a request for information on a proposed CMS-led national directory of providers in October, one CMS official shared insight Wednesday on the feedback the…
Continue Reading
Jonathan Perlin, CEO of the Joint Commisssion
As I write this article, I am recovering from a power outage that lasted nearly two days due to trees downed by record winds created by the atmospheric…
Georgia policymakers, county officials and the NAACP are asking the federal government to investigate Wellstar Health System’s closure of two Atlanta-area hospitals in predominantly Black neighborhoods.
The latest request came from the Fulton County Commission…
FDA approval of Pfizer nasal spray migraine drug Zavzpret last week means a $475 million payday for Royalty Pharma. The payment stems from a financing deal Pfizer inherited when it acquired rights to the…
Continue Reading
The Food and Drug Administration’s Dr. Robert Califf called on insurers Thursday to help ensure that studies on new drugs in the accelerated approval pathway are still completed.
“I don’t think it’s just a matter…
At the MedCity INVEST conference at the Ritz Carlton in Chicago May 22-24, a panel will focus on violence against healthcare professionals. It’s an unfortunate trend that is on the rise, spurred by misinformation…
Continue Reading
New medications take too long to get into the hands of people who need them – a decade, on average. The leading cause of delays is finding patients for clinical trials, but it shouldn’t…
Continue Reading
Vaccine developer Vaxart contends its pill vaccinations against Covid-19 will be preferable to patients, and potentially more effective than currently available injections. But a different virus offers the biotech a clearer and faster path…
Continue Reading
